Regorafénib N-oxyde-d3 (M2)
Regorafénib N-oxyde-d3 (M2) is the deuterium labeled Regorafénib N-oxyde M2[1]. Regorafénib N-oxyde M2 is an active metabolite of Regorafenib. Regorafenib is a multi-target inhibitor for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1 with IC50s of 13/4.2/46, 22, 7, 1.5 and 2.5 nM, respectively[2].
Product Specifications
CAS Number
1333489-03-4
UNSPSC
12352005
Target
Drug Metabolite; PDGFR
Type
Isotope-Labeled Compounds
Related Pathways
Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Solubility
10 mM in DMSO
Smiles
[2H]C([2H])([2H])NC(C1=CC(OC2=CC(F)=C(C=C2)NC(NC3=CC(C(F)(F)F)=C(C=C3)Cl)=O)=CC=[N+]1[O-])=O
Molecular Formula
C21H12D3ClF4N4O4
Molecular Weight
501.83
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.|[2]Allard M, et al. Simultaneous analysis of regorafenib and sorafenib and three of their metabolites in human plasma using LC-MS/MS. J Pharm Biomed Anal. 2017 Aug 5;142:42-48.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL511997V 500 µL Each
Dnaaf6b Mouse shRNA Lentiviral Particle (Locus ID 331537)
Sign In for Pricing
View Details 
A00410-3-Biotin 100 µg/Vial
Anti-DR5/TNFRSF10B Antibody Picoband® (Biotine Conjugate)
Sign In for Pricing
View Details